Molecular Solutions for GBS Testing


GBS remains one of the leading causes of morbidity and mortality among newborns. In some populations, up to 40% of pregnant women are colonized in the vaginal-rectal area.1 One of every 20 babies infected with GBS die.1 Complications that arise during a neonatal GBS infection are serious and can involve septicemia, pneumonia, meningitis, as well as visual and auditory problems.

BD GeneOhm™ StrepB Assay

The BD GeneOhm™ StrepB Assay is a qualitative in vitro diagnostic test for the rapid detection of Group B Streptococcus (GBS) DNA in pregnant women at the time of delivery or at any other stage of their pregnancy.

More information on BD GeneOhm™ StrepB

BD MAX™ GBS Assay

The BD MAX™ GBS assay is an in vitro diagnostic test for the detection of GBS DNA in Lim Broth cultures obtained from vaginal/rectal swab specimens from antepartum pregnant women. The assay is performed on the BD MAX™ System, which fully-automates cell lysis, nucleic acid extraction, PCR set-up, amplification and detection. It is the only fully automated IVD method for PCR detection of GBS from Lim Broth cleared by the FDA. 

More information on BD MAX™ GBS

 

References
  1. MMWR August 16, 2002; 5 (RR11); 1-22

 

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD